PROCEPT BioRobotics Corp (PRCT): Cash & Equivalents

Annual figures by period end, from SEC filings.

$286.50M
As of 2025-12-31
$227.91M
As of 2026-06-30
+8.9%
3-year compound annual growth
+23.4%
5-year compound annual growth
$333.73M2020-12-31: $100.13M2021-12-31: $304.32M2022-12-31: $221.86M2023-12-31: $257.22M2024-12-31: $333.73M2025-12-31: $286.50M$286.50M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$286.50M-14.1%2026-02-26, Balance as of period end
2024-12-31$333.73M+29.7%2026-02-26, Balance as of period end
2023-12-31$257.22M+15.9%2026-02-26, Balance as of period end
2022-12-31$221.86M-27.1%2025-02-27, Balance as of period end
2021-12-31$304.32M+203.9%2024-02-28, Balance as of period end
2020-12-31$100.13Mn/a2022-03-22, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
PROCEPT BioRobotics Corp (PRCT)2025-12-31$286.50M-14.1%
Angiodynamics Inc (ANGO)2026-05-31$53.86M-3.6%
Tactile Systems Technology Inc (TCMD)2025-12-31$83.45M-11.6%
Lemaitre Vascular Inc (LMAT)2025-12-31$28.24M+10.3%
Orthopediatrics Corp (KIDS)2025-12-31$19.56M-55.4%
Accuray Inc (ARAY)2026-06-30$40.62M-29.2%
Cerus Corp (CERS)2025-12-31$19.96M-1.5%
Mimedx Group, Inc. (MDXG)2025-12-31$166.12M+59.1%
Artivion, Inc. (AORT)2025-12-31$64.91M+21.4%

Compare PRCT, ANGO, TCMD, LMAT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗